The round led by Kivu and Greycroft, with participation from PSG Equity, Morningside Capital, Fortitude Ventures, and existing investor Health 2047. This round demonstrates exceptional investor confidence in HOPPR's ability to innovate and scale in the rapidly evolving medical AI imaging space.

HOPPR is the leading infrastructure platform for building, fine-tuning, and deploying AI foundation models and applications in medical imaging. Purpose-built for developers and PACs vendors, HOPPR offers secure tooling and access to curated data with known provenance, enabling the rapid development of clinically ready AI applications. With integrated quality management systems and support for marketing authorization, HOPPR bridges the gap between innovation and real-world deployment, helping transform diagnostic workflows and improve patient care globally.